Showing 1 - 10 of 10,673
Aktuell weisen die Krankenkassen und der Gesundheitsfonds Überschüsse von über 20 Mrd. Euro auf. Für Daniel Bahr, Bundesminister für Gesundheit, eröffnen diese Überschüsse – neben der Abschaffung der Praxisgebühr – Spielräume für Prämien. Die zentrale Herausforderung an eine...
Persistent link: https://www.econbiz.de/10010877382
Klaus-Dirk Henke, TU Berlin und Wolfram Richter, TU Dortmund, identifizieren in ihrem Kommentar gravierende Ordnungsdefizite beim Wettbewerb im deutschen Gesundheitswesen. Sie gehen solchen Defiziten im Bereich der GKV nach und benennen konkrete Mängel, die von der Politik behoben werden sollten.
Persistent link: https://www.econbiz.de/10010877472
The Asia-Pacific region is confronted with several emerging healthrelated issues. The prevalence of diseases causing high rates of mortality and morbidity, and the lack of skilled health personnel, infrastructure, financial resources and health systems that are responsive to the needs of...
Persistent link: https://www.econbiz.de/10010903987
Este estudio del Centro de Estudios en Protección Social y Economía de la Salud (PROESA) de la Universidad Icesi describe los problemas, las tensiones y los vacíos que esta doble descentralización genera en el Sistema de Seguridad Social en Salud colombiano. Con base en esta evaluación...
Persistent link: https://www.econbiz.de/10010945750
Health workforce planning aims to achieve a proper balance between the supply and demand for different categories of health workers, in both the short and longer-term. Workforce planning in the health sector is particularly important, given the time and cost involved in training new doctors and...
Persistent link: https://www.econbiz.de/10011007219
If profit maximization is the objective of a firm, new information about quality should affect firm behavior only through its effects on market demand. I consider an alternate model in which suppliers are motivated by a desire to perform well in addition to profit. The introduction of quality...
Persistent link: https://www.econbiz.de/10010951269
Dopo il rilascio dell'Autorizzazione all'Immissione in Commercio, un farmaco "H", prima di divenire concretamente disponibile in ospedale, deve completare una trafila che può differire da Regione a Regione, e addirittura, all'interno di una stessa Regione, da ASL ad ASL o da ospedale ad...
Persistent link: https://www.econbiz.de/10010929478
Compared to most Canadian provinces, Québec is endowed with a large and fast growing number of family doctors relative to its population. In spite of this, Québec’s family physicians and the general public regularly report that provincial residents have poor access to healthcare services....
Persistent link: https://www.econbiz.de/10011277901
In this paper, I examine the impact of uninsured patients on the health of the insured, focusing on one health outcome – the in-hospital mortality rate of insured heart attack patients. I employ panel data models using patient discharge and hospital financial data from California (1999-2006)....
Persistent link: https://www.econbiz.de/10011279323
ABSTRACT The high price of cancer drugs has become a world-wide phenomenon. In recent decades, studies have produced ample evidence of rising research and clinical testing costs underlying pharmaceutical innovations. There is a general concurrence that the current model of drug development needs...
Persistent link: https://www.econbiz.de/10011250913